BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29126303)

  • 1. Inhibition of the Mitochondrial Pyruvate Carrier by Tolylfluanid.
    Chen Y; McCommis KS; Ferguson D; Hall AM; Harris CA; Finck BN
    Endocrinology; 2018 Feb; 159(2):609-621. PubMed ID: 29126303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beneficial metabolic effects of insulin sensitizers are not attenuated by mitochondrial pyruvate carrier 2 hypomorphism.
    Vigueira PA; McCommis KS; Hodges WT; Schweitzer GG; Cole SL; Oonthonpan L; Taylor EB; McDonald WG; Kletzien RF; Colca JR; Finck BN
    Exp Physiol; 2017 Aug; 102(8):985-999. PubMed ID: 28597936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endocrine disrupting chemical tolylfluanid alters adipocyte metabolism via glucocorticoid receptor activation.
    Neel BA; Brady MJ; Sargis RM
    Mol Endocrinol; 2013 Mar; 27(3):394-406. PubMed ID: 23340252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel endocrine disruptor tolylfluanid impairs insulin signaling in primary rodent and human adipocytes through a reduction in insulin receptor substrate-1 levels.
    Sargis RM; Neel BA; Brock CO; Lin Y; Hickey AT; Carlton DA; Brady MJ
    Biochim Biophys Acta; 2012 Jun; 1822(6):952-60. PubMed ID: 22387882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a mitochondrial target of thiazolidinedione insulin sensitizers (mTOT)--relationship to newly identified mitochondrial pyruvate carrier proteins.
    Colca JR; McDonald WG; Cavey GS; Cole SL; Holewa DD; Brightwell-Conrad AS; Wolfe CL; Wheeler JS; Coulter KR; Kilkuskie PM; Gracheva E; Korshunova Y; Trusgnich M; Karr R; Wiley SE; Divakaruni AS; Murphy AN; Vigueira PA; Finck BN; Kletzien RF
    PLoS One; 2013; 8(5):e61551. PubMed ID: 23690925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of Mitochondrial Pyruvate Carrier 2 in the Liver Leads to Defects in Gluconeogenesis and Compensation via Pyruvate-Alanine Cycling.
    McCommis KS; Chen Z; Fu X; McDonald WG; Colca JR; Kletzien RF; Burgess SC; Finck BN
    Cell Metab; 2015 Oct; 22(4):682-94. PubMed ID: 26344101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and functional expression of the mitochondrial pyruvate carrier.
    Herzig S; Raemy E; Montessuit S; Veuthey JL; Zamboni N; Westermann B; Kunji ER; Martinou JC
    Science; 2012 Jul; 337(6090):93-6. PubMed ID: 22628554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial pyruvate carrier in Trypanosoma brucei.
    Štáfková J; Mach J; Biran M; Verner Z; Bringaud F; Tachezy J
    Mol Microbiol; 2016 May; 100(3):442-56. PubMed ID: 26748989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular fatty acid level regulates the effect of tolylfluanid on mitochondrial dysfunction and insulin sensitivity in C2C12 skeletal myotubes.
    Davis AF; Thomas AA; Shorter KS; Brown SL; Baumgarner BL
    Biochem Biophys Res Commun; 2018 Oct; 505(2):392-398. PubMed ID: 30262144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial pyruvate import and its effects on homeostasis.
    Vanderperre B; Bender T; Kunji ER; Martinou JC
    Curr Opin Cell Biol; 2015 Apr; 33():35-41. PubMed ID: 25463844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial pyruvate carrier 2 hypomorphism in mice leads to defects in glucose-stimulated insulin secretion.
    Vigueira PA; McCommis KS; Schweitzer GG; Remedi MS; Chambers KT; Fu X; McDonald WG; Cole SL; Colca JR; Kletzien RF; Burgess SC; Finck BN
    Cell Rep; 2014 Jun; 7(6):2042-2053. PubMed ID: 24910426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Mitochondrial Proteins in the Surviving Myocardium after Ischemia Identifies Mitochondrial Pyruvate Carrier Expression as Possible Mediator of Tissue Viability.
    Fernández-Caggiano M; Prysyazhna O; Barallobre-Barreiro J; CalviñoSantos R; Aldama López G; Generosa Crespo-Leiro M; Eaton P; Doménech N
    Mol Cell Proteomics; 2016 Jan; 15(1):246-55. PubMed ID: 26582072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic Mitochondrial Pyruvate Carrier 1 Is Required for Efficient Regulation of Gluconeogenesis and Whole-Body Glucose Homeostasis.
    Gray LR; Sultana MR; Rauckhorst AJ; Oonthonpan L; Tompkins SC; Sharma A; Fu X; Miao R; Pewa AD; Brown KS; Lane EE; Dohlman A; Zepeda-Orozco D; Xie J; Rutter J; Norris AW; Cox JE; Burgess SC; Potthoff MJ; Taylor EB
    Cell Metab; 2015 Oct; 22(4):669-81. PubMed ID: 26344103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial metabolism of pyruvate is essential for regulating glucose-stimulated insulin secretion.
    Patterson JN; Cousteils K; Lou JW; Manning Fox JE; MacDonald PE; Joseph JW
    J Biol Chem; 2014 May; 289(19):13335-46. PubMed ID: 24675076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased Mitochondrial Pyruvate Transport Activity in the Diabetic Heart: ROLE OF MITOCHONDRIAL PYRUVATE CARRIER 2 (MPC2) ACETYLATION.
    Vadvalkar SS; Matsuzaki S; Eyster CA; Giorgione JR; Bockus LB; Kinter CS; Kinter M; Humphries KM
    J Biol Chem; 2017 Mar; 292(11):4423-4433. PubMed ID: 28154187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial pyruvate carrier inhibitors improve metabolic parameters in diet-induced obese mice.
    Hodges WT; Jarasvaraparn C; Ferguson D; Griffett K; Gill LE; Chen Y; Ilagan MXG; Hegazy L; Elgendy B; Cho K; Patti GJ; McCommis KS; Finck BN
    J Biol Chem; 2022 Feb; 298(2):101554. PubMed ID: 34973337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MPC1-like Is a Placental Mammal-specific Mitochondrial Pyruvate Carrier Subunit Expressed in Postmeiotic Male Germ Cells.
    Vanderperre B; Cermakova K; Escoffier J; Kaba M; Bender T; Nef S; Martinou JC
    J Biol Chem; 2016 Aug; 291(32):16448-61. PubMed ID: 27317664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans.
    Bricker DK; Taylor EB; Schell JC; Orsak T; Boutron A; Chen YC; Cox JE; Cardon CM; Van Vranken JG; Dephoure N; Redin C; Boudina S; Gygi SP; Brivet M; Thummel CS; Rutter J
    Science; 2012 Jul; 337(6090):96-100. PubMed ID: 22628558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary exposure to the endocrine disruptor tolylfluanid promotes global metabolic dysfunction in male mice.
    Regnier SM; Kirkley AG; Ye H; El-Hashani E; Zhang X; Neel BA; Kamau W; Thomas CC; Williams AK; Hayes ET; Massad NL; Johnson DN; Huang L; Zhang C; Sargis RM
    Endocrinology; 2015 Mar; 156(3):896-910. PubMed ID: 25535829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mitochondrial pyruvate carrier mediates high fat diet-induced increases in hepatic TCA cycle capacity.
    Rauckhorst AJ; Gray LR; Sheldon RD; Fu X; Pewa AD; Feddersen CR; Dupuy AJ; Gibson-Corley KN; Cox JE; Burgess SC; Taylor EB
    Mol Metab; 2017 Nov; 6(11):1468-1479. PubMed ID: 29107293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.